Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Pakistan Pharmaceuticals and Healthcare Report Q2 2008

Published by: Business Monitor International

Published: May. 29, 2008 - 62 Pages


Table of Contents


Executive Summary
Pakistan Pharmaceutical Industry SWOT
Pakistan Political SWOT
Pakistan Economic SWOT
Pakistan Business Environment SWOT
Pharmaceutical Business Environment Ratings
Business Environment Ranking
Table: Pharmaceutical Business Environment Rankings
Limits Of Potential Returns
Risks To Realisation Of Returns
Pakistan - Market Summary
Regulatory Regime
Intellectual Property Regime
Table: Healthcare And Pharmaceutical Companies That Are Members Of The American Business Council Of Pakistan
Counterfeit Drugs
Pricing And Reimbursement Regime
Industry Trends And Developments
Pharmaceutical Sector
Table: Pakistan’s Pharmaceutical Market In 6
Domestic Industry
Multinational Sector
Traditional Medicine
Epidemiology
Research And Development
Retail Sector
International Co-operation
Industry Forecast Scenario
Overall Market Forecast
Table: Pakistan’s Drug Market Forecast Indicators
Key Growth Factors - Industry
Table: Pakistan’s Health Expenditure Indicators
Key Growth Factors - Macroeconomic
Table: Pakistan Economic Activity
Prescription Market Forecast
Table: Pakistan’s Prescription Drugs Market Forecasts (US$mn unless otherwise stated)
OTC Market Forecast
Table: Pakistan’s OTC Drugs Market Forecasts (US$mn unless otherwise stated)
Generics And Patented Market Forecasts
Table: Pakistan Generic Drugs Market Forecast Indicators
Export/Import Forecasts
Table: Pakistan’s Pharmaceutical Trade Data And Forecasts (US$mn)
Other Healthcare Data Forecasts
Table: Other Healthcare Data And Forecasts
Key Risks To BMI’s Forecast Scenario
Competitive Landscape
Company Profiles
Leading Multinational Manufacturers
GlaxoSmithKline
Pfizer
Abbott Laboratories
Novartis
Sanofi-Aventis
Merck & Co
Wyeth
Domestic Manufacturers
Hilton Pharma
Efroze Chemical Industries
Ferozsons Laboratories
BMI Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources


Abstract

Although Pakistan’s pharmaceutical and healthcare sectors are expanding and evolving rapidly, about half the population has no access to modern medicines. Clearly this presents an opportunity, but much more work needs to be done by the government and industry stakeholders. The value of pharmaceuticals sold in 2007 exceeded US$ 1.4bn, which equates to per capita consumption of less than US$ 10 per year. By 2012, BMI is expecting medicine sales to exceed US$ 2.3bn.

Demonstrating ongoing commitment to improving the health of its people, Pakistan will install its first disease monitoring system. The sophisticated software allows disparate incidences of disease outbreaks to be collated centrally, enabling the appropriate action to be taken. BMI welcomes the development, which should go some way to reducing the vast burden of disease in Pakistan.

Due to erosion of margins, pharmaceutical companies called on Pakistan's government in Q208 to allow them to increase the price of medicines. The firms said that the price of drugs had remained stable for the last five years, while the cost of production has risen by one-fifth over the same period. At that time, it was BMI's view that the price controls would remain in place for the medium term, primarily because oft he widespread problem of expired medicines being sold. This will put pressure on all players, but local firms are likely to suffer more than the multinationals.

Following a breakdown in relations during 2007, there were growing signs in early 2008 that Pakistan and China were patching up their once close ties. Two Chinese drug makers are looking to establish joint ventures in the South Asian country, while Pakistan has invited China to participate in a gas pipe line originating in Iran.

During early 2008, rotating energy blackouts were limiting pharmaceutical production to domestic consumption and the ongoing political turmoil was putting off global buyers. Hydroelectricity represents one-third of Pakistan's energy supply and droughts during Q108 severely impaired output. This forced the authorities to introduce 'load shedding', or periodic blackouts. The phenomenon is part of daily life in many African countries due to a combination of aging electricity generation infrastructure and the inadequacy of electricity supply to the ever-expanding demand. However, in Pakistan it is usually restricted to summer months, and then only frequently in rural areas.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008